Seeking Alpha

anomaly1

anomaly1
Send Message
View as an RSS Feed
View anomaly1's Comments BY TICKER:
Latest  |  Highest rated
  • Intrexon: Back-End Economics Could Generate Huge Upside [View article]
    top relative strength in biotech today
    Jul 29, 2015. 03:34 PM | Likes Like |Link to Comment
  • Panera Bread reports mixed results amid 2.0 conversion [View news story]
    PNRA is dead money
    Jul 29, 2015. 09:20 AM | Likes Like |Link to Comment
  • Oncothyreon Makes A Big Splash At ASCO 2015 [View article]
    Bought $3.29- $3.32 . Double or triple in a few months.
    Jul 28, 2015. 10:34 AM | 1 Like Like |Link to Comment
  • Stratasys up 2.9% on pre-earnings Dougherty upgrade [View news story]
    This is where you sell SSYS on the unjustified upgrade. What channel checks? HP will compete with all comapanies, including SSYS.

    Sell while you can.
    Jul 27, 2015. 10:46 AM | 3 Likes Like |Link to Comment
  • Stratasys: A Value Stock In A Growth Industry [View article]
    SSYS is a value trap.

    stock will ride the 52 week lows for rest of 2015
    Jul 27, 2015. 10:32 AM | Likes Like |Link to Comment
  • 3 Reasons Why AK Steel's Recent Rally Will Continue [View article]
    anti-dumping will prevail

    I own 400,000 AKS at 2.50
    Jul 24, 2015. 03:30 PM | Likes Like |Link to Comment
  • JD.com launches U.S. Mall platform for American exporters [View news story]
    JD will be the Amazon of China.
    Jul 20, 2015. 03:26 PM | Likes Like |Link to Comment
  • Exelixis Gets Checkmated By Metastatic Renal Cell Carcinoma [View article]
    FYI I am short, but not due to this article. Average 5.85.
    Jul 20, 2015. 03:23 PM | Likes Like |Link to Comment
  • Exelixis Gets Checkmated By Metastatic Renal Cell Carcinoma [View article]
    It doesnt matter if anybody, including the author, is short.

    There is little/no reason for EXEL market cap to increase into >$1B area for non-statistical data in mid PIII trial, especially since the company is cash poor with debt.
    Jul 20, 2015. 03:22 PM | 2 Likes Like |Link to Comment
  • Exelixis Gets Checkmated By Metastatic Renal Cell Carcinoma [View article]
    another pipe dream drug
    Jul 20, 2015. 03:12 PM | Likes Like |Link to Comment
  • Exelixis Gets Checkmated By Metastatic Renal Cell Carcinoma [View article]
    how do you even calculate that market cap?

    Please justify your valuation for early P3 data without statistical signifigance for a $400M total market potential.
    Jul 20, 2015. 03:07 PM | 1 Like Like |Link to Comment
  • HyperAcute Pancreas Will Go To The Wire [View article]
    Dreamers think $NLNK will get bought.

    $40 is overvalued for this company.
    Jul 20, 2015. 02:52 PM | Likes Like |Link to Comment
  • Exelixis Gets Checkmated By Metastatic Renal Cell Carcinoma [View article]
    EXEL is a strong sell

    partner for cabozantinib will not happen
    Jul 20, 2015. 02:51 PM | 1 Like Like |Link to Comment
  • HyperAcute Pancreas Will Go To The Wire [View article]
    NLNK co mgmt puts out the pump press releases and analysts' upgrades.

    SELL at $54.
    Jul 17, 2015. 05:08 PM | Likes Like |Link to Comment
  • NewLink Genetics Shares Immuno-Oncology Vision at Investor Day [View article]
    insiders are selling stock NLNK
    Jul 17, 2015. 02:34 PM | Likes Like |Link to Comment
COMMENTS STATS
951 Comments
573 Likes